Rapid monitoring of virus-like particles using an optical biosensor: a feasibility study

scientific article published in August 1998

Rapid monitoring of virus-like particles using an optical biosensor: a feasibility study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0168-1656(98)00092-3
P698PubMed publication ID9772753

P50authorSophia TsokaQ40949843
P2093author name stringHoare M
Brookman JL
Gill A
Tsoka S
P2860cites workAnalysis of kinetic data of antibody-antigen interaction from an optical biosensor by exponential curve fittingQ36821120
Polyvalent recombinant antigens: a new vaccine strategyQ39285249
Hybrid Ty virus-like particlesQ40680966
Processing of TY1 proteins and formation of Ty1 virus-like particles in Saccharomyces cerevisiaeQ41372450
Analysis of TYA protein regions necessary for formation of the Ty1 virus-like particle structure.Q45787168
An immunological analysis of Ty1 virus-like particle structureQ45789404
The expression of hybrid HIV:Ty virus-like particles in yeastQ45834296
A retrovirus-like strategy for expression of a fusion protein encoded by yeast transposon Ty1.Q48382127
Determination of rate and equilibrium binding constants for macromolecular interactions using surface plasmon resonance: use of nonlinear least squares analysis methods.Q52392958
Kinetics of Protein-Protein Interactions at the Surface of an Optical BiosensorQ57564216
P433issue2
P921main subjectbiosensorQ669391
P304page(s)147-153
P577publication date1998-08-01
P1433published inJournal of BiotechnologyQ6294860
P1476titleRapid monitoring of virus-like particles using an optical biosensor: a feasibility study
P478volume63

Reverse relations

cites work (P2860)
Q39527934Detection of non-PCR amplified S. enteritidis genomic DNA from food matrices using a gold-nanoparticle DNA biosensor: a proof-of-concept study
Q74317647Influence of a poly-ethylene glycol spacer on antigen capture by immobilized antibodies
Q77800198Rapid monitoring of recombinant protein products: a comparison of current technologies
Q34678977Reduction of animal use in human vaccine quality control: opportunities and problems

Search more.